Similar articles

• Chronic lung disease and cystic fibrosis phenotype in prolidase deficiency: a newly recognized association.

  Luder AS, Mandel H, Khayat M, Gurevich I, Frankel P, Rivlin J, Falik-Zaccai TC. Luder AS, et al. J Pediatr. 2007 Jun;150(6):656-8, 658.e1. doi: 10.1016/j.jpeds.2007.03.025. J Pediatr. 2007. PMID: 17517257
• [New therapeutic approaches in cystic fibrosis].

  Vestner A, Schrepfer B, Kockler J, Mohr F, Zündorf I, Dingermann T. Vestner A, et al. Pharm Unserer Zeit. 2008;37(5):354-5. doi: 10.1002/pauz.200890069. Pharm Unserer Zeit. 2008. PMID: 18729285 German. No abstract available.
• Screening for mutations in the cystic fibrosis transmembrane regulator gene in an infertility clinic.

  Slostad J, Stein QP, Flanagan JD, Hansen KA. Slostad J, et al. Fertil Steril. 2007 Dec;88(6):1687-8. doi: 10.1016/j.fertnstert.2007.01.065. Epub 2007 May 7. Fertil Steril. 2007. PMID: 17482604
• The study of cystic fibrosis transmembrane conductance regulator gene mutations in a group of patients from Romania.

  Frenţescu L, Brownsell E, Hinks J, Malone G, Shaw H, Budişan L, Bulman M, Schwarz M, Pop L, Filip M, Tomescu E, Moşescu S, Popa I, Benga G. Frenţescu L, et al. J Cyst Fibros. 2008 Sep;7(5):423-8. doi: 10.1016/j.jcf.2008.03.004. Epub 2008 May 7. J Cyst Fibros. 2008. PMID: 18467194
• Potential role of the "NADPH oxidases" (NOX/DUOX) family in cystic fibrosis.

  Pongnimitprasert N, El-Benna J, Foglietti MJ, Gougerot-Pocidalo MA, Bernard M, Braut-Boucher F. Pongnimitprasert N, et al. Ann Biol Clin (Paris). 2008 Nov-Dec;66(6):621-9. doi: 10.1684/abc.2008.0285. Ann Biol Clin (Paris). 2008. PMID: 19091660 Review.